期刊文献+

地高辛标记探针检测重组双功能水蛭素中的DNA残留量 被引量:2

Analysis for Residual DNA in Recombinant Double Functions Hirudin Using Digoxin Labeled Probe
暂未订购
导出
摘要 为检测注射用重组双功能水蛭素半成品中的DNA残留量 ,应用地高辛标记重组双功能水蛭素工程菌DNA ,并以此为DNA探针进行点杂交 ,同时做特异性及灵敏度实验。结果证明 ,该方法检测最低限值可达1pg ,且重复性好 ,特异性强 ,操作较简便 。 DNA of engineering bacteria of recombinant double functions hirudin were labeled by Digoxin and used as probe for dot hybridization to detect residual DNA in semi-finished products of recombinant double functions hirudin for injection. At the same time, specificity and sensitivity experiments were performed. It was proved by experimental results that the lowest volume of detection was up to 1 pg. This method had good repeatability and specificity, simple operation, and was competent for quality control in preparation technique of recombinant double functions hirudin and assay for semi-finished products.
出处 《药物生物技术》 CAS CSCD 2004年第6期392-394,共3页 Pharmaceutical Biotechnology
关键词 地高辛标记探针 点杂交法 水蛭素 DNA残留量 Digoxin labeled probe, Dot hybridization, Hirudin, Residual DNA
  • 相关文献

参考文献3

  • 1莫炜,张艳玲,王龙生,杨新英,宋后燕.重组双功能水蛭素的发酵、纯化和鉴定[J].生物工程学报,2004,20(1):126-129. 被引量:8
  • 2Ji X, Lee K, DiPaolo B. High-sensitivity hybridization assay for quantitation of residual E.coli DNA[J].Biotechniques, 2002,32: 1162.
  • 3Riggin A, Luu V T, Lobdell J K, et al. A non-isotopic probe-hybridization assay for residual DNA in biopharmaceuticals[J]. J Pharm Biomed Anal, 1997,16: 561.

二级参考文献2

共引文献7

同被引文献18

  • 1佘清.第57届WHO生物制品标准化专家委员会会议简况[J].中国药品标准,2007,8(1):77-78. 被引量:8
  • 2刘君,张振龙.地高辛标记探针检测重组人干扰素β_(1b)中DNA残留量[J].微生物学免疫学进展,2007,35(2):19-21. 被引量:5
  • 3MARTINS S A M, PRAZERES D M F, CABRAL M S, et al. Comparison of real-time polymerase chain reaction and hybridization assays for the detection of E. coli genomic DNA in process sample and pharmaceutical grade plasmid DNA products [ J]. Anl Biochem, 2003,322 : 127 - 129.
  • 4JI X, LEE K, DIPAOLO B. Highsensitivity hybrization assay for quantitation of residual E. coli DNA [ J ]. Biotechniq, 2002,32 : 1162.
  • 5Akbar S M, Hiasa Y, Mishiro S, et al. Treatment of hepatitis B virus - infected patients: utility of therapeutic recommendations in developing eountries [ J]. Expert Opinion on Pharmacniherapy, 2009, 10 ( 10 ) : 1605 - 1614.
  • 6Ren S, Yu H, Zhang H, et al. Polymorphisms of interferon - inducible genes OAS associated with interferon - alpha treatment ~sponse in chronic HBV infection [ J ]. Antiviral Researh, 2011, 89 ( 3 ) :232 - 237.
  • 7Zhu Y, Qin B, Xiao C, et al. Cell -type specific interferon stimulated gene staining in liver underlies response to interferon therapy in chrnnic HBV infected patients [J]. Digestive Disease and Sciences, 2012, 57 (9) :2355 -2361.
  • 8Lu J J, Chen E Q, Yang J H, et al. A mutation in the interferon regu- latory element of HBV may influence the response of interferon treatment in chronic hepatitis B patients [ J]. Virology Journal, 2012, 9 : 10.
  • 9Stel ' makh V V. Possibilities of using interferon - induction therapy during latent HBV infection [J]. Eksperimental' naiai Klinicheskaia Farmakologiia , 2011, 74 ( 5 ) :35 - 39.
  • 10Okunev O V, Gil' chuk P V, lrodov D M, et al. Production and char- acterization of the single chain antibodies against human alpha2b - interfer- on [ J ]. Ukrainskii Biokhimicheskii Zhurnal , 2005, 77 ( 5 ) : 106 -115.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部